InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,162.80
(
0.60%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.17
(
0.02%
)
Bitcoin
64,371.80
(
-0.17%
)
Post# of 251604
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 207091

Tuesday, 01/24/2017 10:14:20 AM

Tuesday, January 24, 2017 10:14:20 AM

Post# of 251604
ABBV/ENTA—EMA grants accelerated assessment for G/P HCV regimen:

http://finance.yahoo.com/news/enanta-announces-ema-grants-accelerated-090500651.html

EMA accelerated assessment is similar to FDA’s BTD and priority review. As a result of the AA designation, the CHMP could approve G/P as early as 2H17.

Please chase the links in #msg-127281791 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up